3649 results for «358»
3649 results
PCR Tokyo Valves 2019 Opening Ceremony
16 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to discover the slides of PCR Tokyo Valves 2019 Opening Ceremony, a course which is expanding to become the major Asian forum in valvular interventions.
Closing Ceremony - PCR Tokyo Valves 2019
17 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to discover the slides of the PCR Tokyo Valves 2019 closing ceremony, including the best clinical case presenters awards.
EAPCI-PCR Fellows Course - Opening Ceremony
20 May 2019 – From EuroPCR 2019
Consult this session to discover the EAPCI-PCR Fellows Course opening ceremony, introducing EAPCI, EuroPCR, Fellows course, and the EAPCI youngs.
Welcome introduction
20 May 2019 – From PCR Innovators Day 2019
Consult this session to watch EuroPCR 2019 welcome introduction, and learn more about what you can expect from PCR Innovators' Day, the unique European forum enabling clinicians, medical experts and innovators to exchange on the latest devices, information technology and e-health.
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
World Heart Day 2023: Reducing the burden of cardiovascular disease globally: beyond stents and balloons!
29 Sep 2023
Global burden of Cardiovascular Disease
Cardiovascular disease (CVD) remains the lead cause of mortality for men and women globally. Our world population in 2023 is 8 billion! Of these, around 620 million people are living with heart and circulatory diseases across the world. Each year around 60...
Author
The Lancet Commission to reduce global burden of cardiovascular disease in women by 2030
29 Aug 2021
Vijay Kunadian summarizes the key points of the LBT session of the ESC congress 2021 held on Sunday, 29 August focusing on the Lancet Commission to reduce the global burden of heart disease in women by 2030.
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
